BELITE BIO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 23 Dec 2025)
What this means for you
Registered since 03 Mar 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88176499
- Registration number
- 6003555
- Mark type
- Stylized text
- Filed
- 31 Oct 2018
- Published for opposition
- 14 May 2019
- Registered
- 03 Mar 2020
- Attorney of record
- David Bell
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of and prevention of ophthalmic disorders; pharmaceutical preparation for the treatment of and prevention of metabolic syndromes; pharmaceutical preparations for the treatment of cancer
- Class 042 — Scientific and technological services: Pharmaceutical research and development services; development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of ophthalmic disorders, metabolic syndromes, and cancer
Owner
- Belite Bio, Inc, Grand Cayman, KY
- Belite Bio, Inc, Grand Cayman, KY
- Belite Bio, Inc, Grand Cayman, KY
Prosecution history
- 23 Dec 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 23 Dec 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Dec 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 20 Sept 2025 — TEAS SECTION 8 & 15 RECEIVED
- 03 Mar 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
- 30 Jan 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Jan 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Jan 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Jan 2020 — USE AMENDMENT FILED
- 23 Jan 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Jan 2020 — TEAS STATEMENT OF USE RECEIVED
- 09 Jul 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 May 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 May 2019 — PUBLISHED FOR OPPOSITION